Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Utah Medical Products (UTMD) EBT (2016 - 2025)

Historic EBT for Utah Medical Products (UTMD) over the last 16 years, with Q3 2025 value amounting to $3.3 million.

  • Utah Medical Products' EBT fell 2081.84% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.6 million, marking a year-over-year decrease of 1970.89%. This contributed to the annual value of $16.8 million for FY2024, which is 1636.22% down from last year.
  • According to the latest figures from Q3 2025, Utah Medical Products' EBT is $3.3 million, which was down 2081.84% from $3.8 million recorded in Q2 2025.
  • In the past 5 years, Utah Medical Products' EBT registered a high of $5.6 million during Q4 2022, and its lowest value of $3.3 million during Q3 2025.
  • In the last 5 years, Utah Medical Products' EBT had a median value of $4.8 million in 2024 and averaged $4.6 million.
  • In the last 5 years, Utah Medical Products' EBT surged by 14405.67% in 2021 and then plummeted by 2796.49% in 2024.
  • Over the past 5 years, Utah Medical Products' EBT (Quarter) stood at $5.2 million in 2021, then rose by 7.91% to $5.6 million in 2022, then fell by 10.27% to $5.0 million in 2023, then decreased by 27.96% to $3.6 million in 2024, then decreased by 8.44% to $3.3 million in 2025.
  • Its EBT stands at $3.3 million for Q3 2025, versus $3.8 million for Q2 2025 and $3.9 million for Q1 2025.